Cerebras Systems vs. Innodata: Which AI-Driven Tech Stock Is a Better Buy in 2026?

Key Points

• Cerebras Systems produces massive wafer-scale chips that drastically accelerate the training and execution of complex artificial intelligence models.
• Innodata provides the critical data engineering and human expertise required by major technology firms to build reliable generative AI systems.
• Which high-growth artificial intelligence stock deserves a spot in your portfolio for the long term?
• 10 stocks we like better than Cerebras Systems ›

Artificial intelligence stocks continue to reshape the market in 2026 as investors hunt for long-term winners. Choosing between hardware powerhouse Cerebras Systems (NASDAQ:CBRS) and data specialist Innodata (NASDAQ:INOD) requires a look at two distinct strategies.

Cerebras designs massive, wafer-sized chips intended to power the next generation of artificial intelligence models. Meanwhile, Innodata provides the specialized human expertise and data engineering services that ensure those models are accurate and reliable. Both companies benefit from the same industry tailwinds, but their financial health and market valuations present starkly different paths.

The case for Cerebras Systems

Cerebras sells AI computing infrastructure, including its unique wafer-scale platform that uses a single massive chip to accelerate processing speeds. Its customers are spread across North America and Europe, focusing on high-performance deployments for research and specialized cloud services. In its latest official filing, the company reported having 708 employees as of late 2025 to support its global mission of making advanced computing more accessible.

In FY 2025, revenue reached $510.0 million, representing significant revenue growth of roughly 75.7% over the prior year. While Cerebras reported a GAAP net income of $237.8 million, this was entirely driven by a $363.3 million one-time, non-cash accounting adjustment, masking an actual operating loss of $75.7 million.

As of its December 2025 balance sheet, the debt-to-equity ratio was roughly -0.5x, which means total liabilities exceed shareholder equity. The current ratio, which measures a company's ability to pay short-term debts with short-term assets, was close to 2.1x. Free cash flow, or the cash left after paying for operating costs and capital investments, was negative $392.8 million for the fiscal year, though free cash flow equals cash flow from operations minus capital expenditures.

The case for Innodata

Innodata provides the data engineering and human expertise necessary for building large-scale generative AI systems for the world's largest semiconductor stocks and software giants. The company counts five of the "Magnificent Seven" among its clients, including Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG) and Amazon (NASDAQ:AMZN). However, one major customer accounted for approximately 58% of total revenue in FY 2025, and customer concentration like this adds a layer of risk to the business.

In FY 2025, revenue reached approximately $251.7 million, which is a revenue growth of nearly 47.6% compared to the previous year. Net income for the period was close to $32.2 million, resulting in a net margin of roughly 12.8%. While revenue increased, this net margin, which shows how much profit is kept from each dollar earned, saw a slight decrease from the 16.8% reported in FY 2024.

As of its December 2025 balance sheet, the debt-to-equity ratio was 0.0x, indicating the company has no traditional debt relative to its equity. The current ratio stands at approximately 2.7x, suggesting a healthy ability to cover upcoming bills with liquid assets. Free cash flow was nearly $35.6 million, though note that stock-based compensation represented roughly 23.8% of operating cash flow, which inflates reported cash generation since this is a non-cash expense.

Risk profile comparison

Cerebras faces intense competition in the AI hardware space from established giants such as Nvidia (NASDAQ:NVDA). The company must continue to innovate its wafer-scale technology to justify its high development costs and keep pace with rival hardware. Additionally, it faces risks associated with scaling its manufacturing processes and maintaining a consistent pipeline of enterprise customers to reach sustainable positive cash flow.

Innodata deals with extreme revenue concentration, as a single client provides more than half of its annual revenue and accounts receivable. It also navigates a rapidly changing technological landscape where it competes with massive firms like Accenture (NYSE:ACN) and Cognizant Technology Solutions (NASDAQ:CTSH). Geopolitical risks are also prominent, as the company operates in over 70 countries and faces legacy litigation in the Philippines that could impact its financial position.

Valuation comparison

| Metric | Cerebras Systems | Innodata | |---|---|---| | Forward P/E | N/A | 45.5x | | P/S ratio | 69.7x | 7.1x |

Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.

Which stock would I buy in 2026?

I'd go with Innodata. While Cerebras is grabbing headlines with wafer-scale chips and OpenAI deals, Innodata has spent 12 consecutive quarters doing something harder to find in AI: growing consistently and becoming more profitable along the way. A broadening customer base keeps reducing its concentration risk, and the addition of a major frontier AI lab as a new customer adds a dimension to the story that most investors have not fully priced in yet.

Cerebras is doing technically impressive work, building inference chips that are faster than most alternatives. A multibillion-dollar supply deal with OpenAI signals serious institutional demand. Revenue nearly doubled year over year, and the company raised its full-year outlook after going public in May.

But Cerebras is still losing money, gross margins are shrinking as it scales, and the stock has dropped sharply since its IPO despite strong results. The pattern suggests investors are not yet convinced the business model holds up at scale.

For investors with patience and a long horizon, Innodata's proven execution and improving profitability make it the more comfortable place to put your money right now.

Should you buy stock in Cerebras Systems right now?

Before you buy stock in Cerebras Systems, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Cerebras Systems wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $406,141! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,347,745!

Now, it’s worth noting Stock Advisor’s total average return is 940% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

**Stock Advisor returns as of September 18, 2026. *

Sara Appino has positions in Amazon and Nvidia. The Motley Fool has positions in and recommends Accenture Plc, Alphabet, Amazon, Innodata, and Nvidia. The Motley Fool recommends Cognizant Technology Solutions and recommends the following options: long January 2028 $260 calls on Accenture Plc and short January 2028 $280 calls on Accenture Plc. The Motley Fool has a disclosure policy.